RA Capital Management files initial beneficial ownership statement in Inhibikase TherapeuticsPUBT·Jul 17 at 04:55 PMIKT0.00%
Biotech Stocks Hit 52-Week Highs - TOI, IKT, ANRO, ELV, PRVArttnews·Jul 15 at 02:55 AMANRO-0.26%IKT0.00%
Inhibikase Therapeutics sells 25,000,000 shares via ATM for gross proceeds of $50 millionPUBT·Jul 14 at 07:01 AMIKT0.00%
Inhibikase grants stock options for 981,243 shares to seven new hires under inducement plan at $2.03 per sharePUBT·Jul 2 at 03:01 PMIKT0.00%
Bank of America Securities Reaffirms Their Buy Rating on Inhibikase Therapeutics (IKT)Tip Ranks·May 15 at 04:50 AMIKT0.00%LABU-3.22%
Inhibikase Therapeutics, Inc. 1Q 2026: Revenue $0 Net income $(16.4) M, EPS $(0.10) — 10-Q SummaryTradingView·May 12 at 03:41 PMIKT0.00%FBT-0.57%
